{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T21:57:19Z","timestamp":1785794239341,"version":"3.56.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["309611\/2018-0"],"award-info":[{"award-number":["309611\/2018-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/010.001925\/2015"],"award-info":[{"award-number":["E-26\/010.001925\/2015"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/203.056\/2017"],"award-info":[{"award-number":["E-26\/203.056\/2017"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013101","name":"National Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013101","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.bone.2021.116014","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T22:07:45Z","timestamp":1621462065000},"page":"116014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["CD8+ T cells from experimental in situ breast carcinoma interfere with bone homeostasis"],"prefix":"10.1016","volume":"150","author":[{"given":"Ana Carolina","family":"Monteiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Bonomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2021.116014_bb0005","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bone.2021.116014_bb0010","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2021.116014_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bonekey.2015.122","article-title":"Mechanisms of osteolytic and osteoblastic skeletal lesions","volume":"4","author":"David Roodman","year":"2015","journal-title":"Bonekey Rep."},{"key":"10.1016\/j.bone.2021.116014_bb0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nm0107-25","article-title":"Bone-breaking cancer treatment","volume":"13","author":"Roodman","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2021.116014_bb0025","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41577-019-0178-8","article-title":"Osteoimmunology: evolving concepts in bone\u2013immune interactions in health and disease","volume":"19","author":"Tsukasaki","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bone.2021.116014_bb0030","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/35046102","article-title":"T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-\u03b3","volume":"408","author":"Takayanagi","year":"2000","journal-title":"Nature."},{"key":"10.1016\/j.bone.2021.116014_bb0035","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/35046196","article-title":"Bone versus immune system","volume":"408","author":"Arron","year":"2000","journal-title":"Nature."},{"key":"10.1016\/j.bone.2021.116014_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.00058","article-title":"Osteoimmunology: a current update of the interplay between bone and the immune system","volume":"11","author":"Guder","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bone.2021.116014_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0068171","article-title":"T cells induce pre-metastatic osteolytic disease and help bone metastases establishment in a mouse model of metastatic breast cancer","volume":"8","author":"Monteiro","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2021.116014_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1002194","article-title":"Patterns of immune infiltration in breast cancer and their clinical implications: a gene-expression-based retrospective study","volume":"13","author":"Ali","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.bone.2021.116014_bb0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2009.06.018","article-title":"CD4+ T cells regulate pulmonary metastasis of mammary carcinomas by enhancing Protumor properties of macrophages","volume":"16","author":"DeNardo","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bone.2021.116014_bb0060","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/s41590-018-0145-8","article-title":"Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific","volume":"19","author":"Michea","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bone.2021.116014_bb0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.it.2015.11.008","article-title":"Neutrophils in the tumor microenvironment","volume":"37","author":"Powell","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bone.2021.116014_bb0070","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2016.03.012","article-title":"Expansion and activation of CD103+ dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF inhibition","volume":"44","author":"Salmon","year":"2016","journal-title":"Immunity."},{"key":"10.1016\/j.bone.2021.116014_bb0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10555-007-9100-0","article-title":"Immune cells as mediators of solid tumor metastasis","volume":"27","author":"DeNardo","year":"2008","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bone.2021.116014_bb0080","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bone.2021.116014_bb0085","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41586-020-2611-3","article-title":"cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity","volume":"584","author":"Ferris","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.bone.2021.116014_bb0090","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc2618","article-title":"Microenvironmental regulation of metastasis","volume":"9","author":"Joyce","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bone.2021.116014_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00184","article-title":"A T cell view of the bone marrow","volume":"7","author":"Bonomo","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bone.2021.116014_bb0100","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ccell.2017.02.008","article-title":"Obstacles posed by the tumor microenvironment to T cell activity: a case for synergistic therapies","volume":"31","author":"Anderson","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bone.2021.116014_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2019.10.009","article-title":"CD4+ T cell help is required for the formation of a cytolytic CD8+ T cell subset that protects against chronic infection and cancer","volume":"51","author":"Zander","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.bone.2021.116014_bb0110","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cell.2016.12.022","article-title":"Systemic immunity is required for effective cancer immunotherapy","volume":"168","author":"Spitzer","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bone.2021.116014_bb0115","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/jcp.27150","article-title":"The viral approach to breast cancer immunotherapy","volume":"234","author":"Arab","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bone.2021.116014_bb0120","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers","volume":"21","author":"Gentles","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2021.116014_bb0125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10549-017-4161-4","article-title":"Higher densities of Foxp3+ regulatory T cells are associated with better prognosis in triple-negative breast cancer","volume":"163","author":"Yeong","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bone.2021.116014_bb0130","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bone.2021.116014_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bone.2021.116014_bb0140","first-page":"606","article-title":"Increase of regulatory T cells in the peripheral blood of cancer patients","volume":"9","author":"Wolf","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bone.2021.116014_bb0145","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1200\/JCO.2006.05.9584","article-title":"Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse","volume":"24","author":"Bates","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bone.2021.116014_bb0150","doi-asserted-by":"crossref","DOI":"10.1007\/s12272-019-01146-9","article-title":"T helper 17 (Th17) cells and interleukin-17 (IL-17) in cancer","author":"Chang","year":"2019","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.bone.2021.116014_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2019.00685","article-title":"4T1 mammary carcinoma colonization of metastatic niches is accelerated by obesity","volume":"9","author":"Evangelista","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bone.2021.116014_bb0160","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10549-016-4036-0","article-title":"Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast","volume":"161","author":"Campbell","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bone.2021.116014_bb0165","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.humpath.2017.09.012","article-title":"The CD4\/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer","volume":"69","author":"Wang","year":"2017","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bone.2021.116014_bb0170","doi-asserted-by":"crossref","first-page":"17462","DOI":"10.18632\/oncotarget.3958","article-title":"CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome","volume":"6","author":"Huang","year":"2015","journal-title":"Oncotarget."},{"key":"10.1016\/j.bone.2021.116014_bb0175","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10549-014-3185-2","article-title":"The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis","volume":"148","author":"Ibrahim","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bone.2021.116014_bb0180","first-page":"2673","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction","volume":"203","author":"Sato","year":"2006"},{"key":"10.1016\/j.bone.2021.116014_bb0185","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bone.2013.05.024","article-title":"Osteoclast-induced Foxp3+ CD8 T-cells limit bone loss in mice","volume":"56","author":"Buchwald","year":"2013","journal-title":"Bone."},{"key":"10.1016\/j.bone.2021.116014_bb0190","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1002\/1521-4141(200107)31:7<2179::AID-IMMU2179>3.0.CO;2-X","article-title":"Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8+ T cells","volume":"31","author":"Choi","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bone.2021.116014_bb0195","doi-asserted-by":"crossref","first-page":"726","DOI":"10.4049\/jimmunol.1600253","article-title":"Osteoclast-primed Foxp3 + CD8 T cells induce T-bet, eomesodermin, and IFN-\u03b3 to regulate bone resorption","volume":"197","author":"Shashkova","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.bone.2021.116014_bb0200","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/jbmr.2472","article-title":"A bone anabolic effect of RANKL in a murine model of osteoporosis mediated through FoxP3+ CD8 T cells","volume":"30","author":"Buchwald","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116014_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038199","article-title":"Osteoclast activated FoxP3 + CD8 + T-cells suppress bone resorption in vitro","volume":"7","author":"Buchwald","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2021.116014_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2019.00578","article-title":"Foxp3+ regulatory T cells in bone and hematopoietic homeostasis","volume":"10","author":"Fischer","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bone.2021.116014_bb0215","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1182\/blood-2003-04-1320","article-title":"Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes","volume":"102","author":"Cosmi","year":"2003","journal-title":"Blood."},{"key":"10.1016\/j.bone.2021.116014_bb0220","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fimmu.2015.00171","article-title":"Human and mouse CD8+CD25+FOXP3+ regulatory T cells at steady state and during interleukin-2 therapy","volume":"6","author":"Churlaud","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bone.2021.116014_bb0225","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1182\/blood-2011-12-396119","article-title":"Identification and expansion of highly suppressive CD8 +FoxP3 + regulatory T cells after experimental allogeneic bone marrow transplantation","volume":"119","author":"Robb","year":"2012","journal-title":"Blood."},{"key":"10.1016\/j.bone.2021.116014_bb0230","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.4049\/jimmunol.1401490","article-title":"Identification and clinical relevance of naturally occurring human CD8 + HLA-DR + regulatory T cells","volume":"193","author":"Arruvito","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.bone.2021.116014_bb0235","first-page":"1","article-title":"Cross-talk between T cells and osteoclasts in bone resorption","volume":"1","author":"D\u2019Amico","year":"2012","journal-title":"Bonekey Rep."},{"key":"10.1016\/j.bone.2021.116014_bb0240","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ni1165","article-title":"Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4","volume":"6","author":"Probst","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bone.2021.116014_bb0245","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1182\/blood-2009-11-255026","article-title":"Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+and CD8+ T cells","volume":"116","author":"Li","year":"2010","journal-title":"Blood."},{"key":"10.1016\/j.bone.2021.116014_bb0250","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s10753-018-0822-7","article-title":"CD8+ Foxp3+ T cells affect alveolar bone homeostasis via modulating Tregs\/Th17 during induced periodontitis: an adoptive transfer experiment","volume":"41","author":"Han","year":"2018","journal-title":"Inflammation."},{"key":"10.1016\/j.bone.2021.116014_bb0255","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/art.27535","article-title":"Increased bone density and resistance to ovariectomy-induced bone loss in FoxP3-transgenic mice based on impaired osteoclast differentiation","volume":"62","author":"Zaiss","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2021.116014_bb0260","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1002\/art.23138","article-title":"Treg cells suppress osteoclast formation: a new link between the immune system and bone","volume":"56","author":"Zaiss","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2021.116014_bb0265","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.ajpath.2017.02.012","article-title":"Interferon-\u03b3 released by activated CD8+ T lymphocytes impairs the calcium resorption potential of osteoclasts in calcified human aortic valves","volume":"187","author":"Nagy","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bone.2021.116014_bb0270","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.4049\/jimmunol.0803897","article-title":"Cross-presentation by osteoclasts induces FoxP3 in CD8 + T cells","volume":"182","author":"Kiesel","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.bone.2021.116014_bb0280","article-title":"Dendritic cells development into osteoclast-type APCs by 4T1 breast tumor T cells milieu boost bone consumption","volume":"115755","author":"Monteiro","year":"2020","journal-title":"Bone."},{"key":"10.1016\/j.bone.2021.116014_bb0285","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1023\/A:1006689719505","article-title":"A novel orthotopic model of breast cancer metastasis to bone","volume":"17","author":"Lelekakis","year":"1999","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.bone.2021.116014_bb0290","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1002\/jbmr.2868","article-title":"Inflammatory osteoclasts prime TNF\u03b1-producing CD4+ T cells and express CX3CR1","volume":"31","author":"Ib\u00e1\u00f1ez","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116014_bb0295","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrc.2017.6","article-title":"Pre-metastatic niches: organ-specific homes for metastases","volume":"17","author":"Peinado","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bone.2021.116014_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2018.03.004","article-title":"Cancer-cell-intrinsic mechanisms shaping the tumor immune landscape","volume":"48","author":"Wellenstein","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.bone.2021.116014_bb0305","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/429373","article-title":"Osteoclasts and CD8 T cells form a negative feedback loop that contributes to homeostasis of both the skeletal and immune systems","volume":"2013","author":"Buchwald","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.bone.2021.116014_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.01408","article-title":"Immune function and diversity of osteoclasts in normal and pathological conditions","volume":"10","author":"Madel","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bone.2021.116014_bb0315","author":"Harbeck","year":"2019","journal-title":"Breast Cancer"},{"key":"10.1016\/j.bone.2021.116014_bb0320","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/s41591-018-0078-7","article-title":"Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis","volume":"24","author":"Savas","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2021.116014_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.03.005","article-title":"A single-cell atlas of the tumor and immune ecosystem of human breast cancer","volume":"177","author":"Wagner","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.bone.2021.116014_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13058-018-1003-1","article-title":"Immune characterization of breast cancer metastases: prognostic implications","volume":"20","author":"Dieci","year":"2018","journal-title":"Breast Cancer Res."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221001769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221001769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:43:42Z","timestamp":1762659822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328221001769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":65,"alternative-id":["S8756328221001769"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2021.116014","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD8+ T cells from experimental in situ breast carcinoma interfere with bone homeostasis","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2021.116014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116014"}}